Multiple API Inhalation Products: Advantages and Challenges
Multiple API products can offer improved efficacy while avoiding the need for patients to administer several drugs from different devices.
The development of inhalable products combining multiple active pharmaceutical ingredients (APIs) enables drug companies to offer effective treatments that align with market demand for patient-centric medications. Despite the benefits, multiple API products can be challenging during the development and manufacturing stages.
Lei Mao, Director of Inhalation Science and Product Development at Recipharm discusses the growing demand for inhalation products that combine multiple APIs, exploring the advantages and disadvantages encountered during development.
Read the full article here.